Avadel pharmaceuticals and jazz pharmaceuticals reach global settlement

Dublin, oct. 22, 2025 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all litigation with jazz pharmaceuticals inc. (“jazz”).
AVDL Ratings Summary
AVDL Quant Ranking